|Min SIP Amount||₹500|
|NAV||₹81.46 (23 Jul 2021)|
|Fund Started||19 Apr 2007|
|Fund Size||₹1,706 Cr|
|Gland Pharma Ltd.||Healthcare||Equity||3.7%|
|Endurance Technologies Ltd.||Automobile||Equity||3.6%|
|Vinati Organics Ltd.||Chemicals||Equity||3.5%|
|Bharat Electronics Ltd.||Engineering||Equity||3.4%|
|Gujarat Gas Ltd.||Energy||Equity||3.3%|
|Persistent Systems Ltd.||Technology||Equity||3.3%|
|JB Chemicals & Pharmaceuticals Ltd.||Healthcare||Equity||3.0%|
|Craftsman Automation Ltd.||Engineering||Equity||2.9%|
|Cholamandalam Investment & Finance Company Ltd.||Financial||Equity||2.8%|
Invesco India Mid Cap Fund Growth is a Equity Mutual Fund Scheme launched by Invesco Mutual Fund. This scheme was made available to investors on 19 Apr 2007. Vinay Paharia is the Current Fund Manager of Invesco India Mid Cap Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹1,706 Cr and the Latest NAV as of 23 Jul 2021 is ₹81.46.
The Invesco India Mid Cap Fund Growth is rated Very High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 1000. For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.